Corbus Pharmaceuticals Holdings, Inc.
CRBPReported to SECin USCIK 0001595097Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 6. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Ben Yong— | Open-market sell | $15,6832,000 shares | Sep 15, 2026 | Ben Yong | $15,683 | Open-market sell | 2,000 | Sep 15, 2026 |
| Nicacio Leonardo VianaChief Medical Officer | Award | nothing paid191,676 shares | Aug 17, 2026 | Nicacio Leonardo VianaChief Medical Officer | nothing paid | Award | 191,676 | Aug 17, 2026 |
| Nicacio Leonardo VianaChief Medical Officer | Award | nothing paid58,333 shares | Aug 17, 2026 | Nicacio Leonardo VianaChief Medical Officer | nothing paid | Award | 58,333 | Aug 17, 2026 |
| Saxena Nishant CChief Business Officer | Open-market buy | $25,0362,600 shares | Aug 12, 2026 | Saxena Nishant CChief Business Officer | $25,036 | Open-market buy | 2,600 | Aug 12, 2026 |
| Cohen YuvalChief Executive Officer | Open-market sell | $171,39617,000 shares | Aug 10, 2026 | Cohen YuvalChief Executive Officer | $171,396 | Open-market sell | 17,000 | Aug 10, 2026 |